CATY(CATY)
CATY
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $882M | $928M |
| Low | $879M | $925M |
| High | $885M | $932M |
| EBITDA Avg | $347M | $365M |
| Low | $346M | $364M |
| High | $348M | $367M |
| EBIT Avg | $332M | $349M |
| Low | $331M | $348M |
| High | $333M | $350M |
| Net Income Avg | $368M | $384M |
| Low | $363M | $384M |
| High | $383M | $419M |
| EPS Avg | $5.49 | $5.90 |
| Low | $5.34 | $5.65 |
| High | $5.63 | $6.16 |
| Analysts (Rev / EPS) | 3 / 4 | 3 / 4 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $218M | $224M | $227M | $225M | $230M | $236M | $238M |
| Low | $217M | $223M | $226M | $224M | $229M | $235M | $237M |
| High | $219M | $225M | $228M | $226M | $231M | $237M | $239M |
| EBITDA Avg | $86M | $88M | $89M | $89M | $90M | $93M | $94M |
| Low | $86M | $88M | $89M | $88M | $90M | $92M | $93M |
| High | $86M | $88M | $90M | $89M | $91M | $93M | $94M |
| EBIT Avg | $82M | $84M | $85M | $85M | $86M | $89M | $89M |
| Low | $82M | $84M | $85M | $84M | $86M | $88M | $89M |
| High | $82M | $84M | $86M | $85M | $87M | $89M | $90M |
| Net Income Avg | $91M | $95M | $97M | $95M | $98M | $102M | $103M |
| Low | $88M | $94M | $97M | $94M | $97M | $102M | $103M |
| High | $94M | $95M | $98M | $96M | $98M | $103M | $104M |
| EPS Avg | $1.35 | $1.40 | $1.45 | $1.41 | $1.45 | $1.52 | $1.53 |
| Low | $1.31 | $1.40 | $1.44 | $1.40 | $1.44 | $1.51 | $1.52 |
| High | $1.39 | $1.41 | $1.45 | $1.42 | $1.46 | $1.53 | $1.54 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |